Search Results

The probes kits are intended for extravascular monitoring of microcirculation blood flow in buried tissues, specifically, in monitoring cerebral blood flow in patients at risk of cerebral ischemia.

The Model BPM2 is a Laser Doppler Blood Perfusion Monitor, which is used to measure microcirculatory blood flow in a variety of clinical applications. Permission to market the BPM2 was granted by FDA on February 13, 1990 (Ref. K896515). The Model SUPR-434 Blunt Needle Probe is a single use fiber optic probe designed for use with the BPM2. These probes are labeled so as to be used for monitoring buried tissue, such as brain parenchyma during and following neurosurgical procedures. Permission to market the Model SUPR-434 ( Note: the SUPR-434 Blunt needle probes model names have since been changed to Trimflo 4314, 4316, 4364 and 4366) was granted on March 21, 1996 (Ref. K951832).

The provided text K961368 is a 510(k) summary for a medical device (Single Use Laser Doppler Probe Kits). It describes the device, its intended use, and argues for substantial equivalence to a predicate device. However, it does not contain any information about a study proving the device meets acceptance criteria, nor does it mention specific acceptance criteria with corresponding performance metrics.

Therefore, I cannot fulfill your request for:

• A table of acceptance criteria and reported device performance.
• Sample size used for the test set or data provenance.
• Number of experts used to establish ground truth or their qualifications.
• Adjudication method.
• MRMC comparative effectiveness study results.
• Standalone performance.
• Type of ground truth used.
• Sample size for the training set.
• How ground truth for the training set was established.

The document focuses on establishing substantial equivalence based on the device being largely the same as existing, cleared devices (the probes themselves) with minor changes (addition of accessories, packaging as a kit, and ETO sterilization). It highlights biocompatibility and sterilization processes, but these are described as general adherence to standards (e.g., AAMI guidelines for sterilization, FDA guidelines for residual levels) rather than a specific study with measured performance against predefined acceptance criteria for the device's primary function.

Ask a specific question about this device

The Single Use Probes are intended for extravascular monitoring of microcirculation blood flow in buried tissues. An example of this application is the monitoring of buried muscle or esophagus following free muscle transfer or esophageal reconstruction, Another example is monitoring soft tissue microcirculation following reconstructive surgery, such as in oral and facial reconstruction. Yet another example is monitoring cerebral blood flow during and following neurosurgery for head trauma.

The Model BPM2 is a Laser Doppler Blood Perfusion Monitor, which is used to measure microcirculatory blood flow in a variety of clinical applications. Permission to market the BPM2 was granted by FDA on February 13, 1990 (Ref K896515). The Model P-433 Needle Probe, Model PR-434 Implantable Prism Probe, and Model P-440 Implantable Soflex Probe are fiber optic probes designed for use with the BPM- These probes are labelled so as to be used for monitoring buried tissue, such as buried muscle following free muscle transfers and cerebral cortex following neurosurgical procedures. Permission to market the Model PR-434 and Model P-433 probes was granted by FDA on September 19, 1988 (Ref K875179). Permission to market the P-440 was granted by FDA on December 12, 1991 (Ref K912446).

The single use probes, SUP-440 Disposable Flat Probe, SUP-433 Disposable Right Angle Needle Probe, and SUPR-434 Disposable Blumt End Needle probe are also fiber optic probes designed for use with the BPM2 They connect to the BPM2 Probe Connector Port on the BPM front panel via a fiber optic interface cable. The tip of the SUP-440 Disposable Flat Profile Probe is similar to the P-440 Soflex Probe in that it includes the termination of the optical fiber which provides right angle light emission, and an outer encapsulation of soft, flexible material. The tip of the SUP-433 Disposable Right Angle Needle Probe and the SUPR-434 Disposable Blunt End Needle Probe are similar to the P-433 Needle Probe in that it includes the termination of the optical fiber in a stainless steel tube and similar to the PR-434 Implantible prism probe in that the probes provide right angle light emission.

This document is a 510(k) summary for a medical device. The information provided is insufficient to answer the request regarding acceptance criteria and a study proving the device meets those criteria, as it does not contain details about specific performance metrics, clinical studies, or acceptance targets.

The provided text focuses on:

• Device Name: Laserflo Blood perfusion Single Use Probes
• Predicate Device: Previous versions of similar probes and the BPM2 monitor
• Device Description: Physical characteristics and function of the probes as accessories to the BPM2 monitor.
• Intended Use: Clinical applications for monitoring microcirculation blood flow in buried tissues.

There is no mention of:

• Specific acceptance criteria (e.g., accuracy, precision, sensitivity, specificity, or correlation values).
• Any studies conducted to demonstrate the device meets performance claims or acceptance criteria.
• Details about sample sizes, data provenance, expert qualifications, or ground truth establishment.
• Comparative effectiveness studies (MRMC) or standalone algorithm performance.

Therefore, I cannot populate the requested table or answer the specific questions based solely on the provided text. The document is essentially a description of the device and its intended use, not a performance evaluation.

Ask a specific question about this device